As vaccine manufacturers announce higher prices for states and the private sector, we find out that it's actually possible to make vaccines affordable. A look at the factors that influence prices, and who stands to benefit
A rice mill worker receives a dose of Covishield, a coronavirus disease (Covid-19) vaccine manufactured by Serum Institute of India, during a Covid-19 vaccination drive at Bavla village on the outskirts of Ahmedabad, India, April 13, 2021. Credit: Amit Dave / Reuters